Stockreport

US FDA puts partial clinical hold on PepGen's muscle disease drug trial [Yahoo! Finance]

PepGen Inc.  (PEPG) 
PDF of ?a rare muscle disease drug, sending its shares plunging over 25% ?in extended trading. The drug, PGN-EDODM1, is being tested for myotonic dystrophy type 1, a genet [Read more]